Advancement in the Development of ASFV Vaccine Technology for Emergency Vaccination
March 1, 2023
In this study, researchers examined ZMAC-4 cell line for its ability to support the replication of two ASF gene-deleted recombinant modified live virus (MLV) vaccine candidates, the ASFV-G-Δ9GL/ΔUK and ASFV-G-ΔMGF.
